Progress in science and technology, while greatly influencing the practice of medicine, has created many new needs. One case in point is the development of the dialysis machine, which has saved thousands of lives, but has also created the need to obtain repeated access to the circulation. It goes without saying that hemodialysis is still the main reason for establishing vascular access. Yet there are now several other indications, which are shown in Table l .'and there are likewise several techniques available, each with its own advantages and disadvantages (Table II) .
Temporary access for a few hours or days can be achieved with a semirigid catheter of a plastic material (such as teflon) that causes minimal tissue reaction. Such catheters, commonly used for measuring central venous and pulmonary artery pressure, are available in single and double lumen configurations. If continuous intravenous therapy is not needed, they may be heparinized and capped after each use (1) . Often used for short-term hemodialysis, they can be inserted percutaneously and have the advantage of not destroying normal structures. The external shunt is a relatively short-lived alternative requiring the ligation of an artery and vein, an unnecessary sacrifice of blood vessels. In all. these tubes and catheters, infection often develops along their tracts, thus rendering them undesirable for long-term use. Permanent access, internal or external, may require synthetic materials. The best long-term method of vascular access is the side-to-side arteriovenous fistula (AVF), first reported in 1966 (2) . Safe and effective, many fistulas constructed over sixteen years ago still function today, a record not equalled by any other method or device. Their creation, however, requires finding an artery relatively free of disease in proximity to a suitable vein. When the artery is diseased or occluded, or the vein is sclerosed, perhaps from drug abuse or intravenous therapy, the vessels may be widely separated and the distance between them must be bridged by prosthetic material. Although the saphenous vein can be used for this purpose, repeated needle punctures will result in sclerosis and aneurysm formation. The first graft material used for access, the Bovine Carotid Heterograft (BCH), is pliable, can be punctured repeatedly, and does not bleed excessively after the needles are withdrawn. Yet not only does BCH deteriorate and develop true aneurysms ( Fig.  1 ), but infection is difficult to manage, because the graft becomes thin and friable while the surrounding tissue reaction is dense. Serious and sometimes fatal hemorrhage has occurred.
The most widely used graft material, polyetrafluorethylene (PTFE), is easy to suture and may be punctured with little bleeding. It allows dense invasion by fibrous tissue to which a single layer of pseudo intima becomes fixed. As with all other inert tubes, it is subject to occlusion and infection. However, occlusion is easily treated by thrombectomy, which may have to be combined with revision of the venous outflow tract. Infection can often be managed without loss of the graft, either by a bypass of the affected segment or by drainage techniques that we have previously reported (3) . Other graft materials include human umbilical vein grafts, which like BCH are also collagen tubes, and thus have similar drawbacks and no significant advantage. Dacron velour grafts are difficult to puncture and offer no advantages in longevity.
Permanent external devices play an increasing role in modern medicine ( Fig. 2 ). For some conditions they may be a method of choice. Permanent long-term cannulation of the central venous system is possible by the use of a soft silicone catheter to which a dacron cuff is fused (4). The silicone material resists thrombosis and may lie in the central venous system for several years without causing problems; the cuff is buried within a subcutaneous tunnel and the resulting fibrous ingrowth retards infection along the tract. Such catheters are ideal for permanent parenteral nutrition or chemotherapy, and for hemophiliacs, requiring frequent administration of blood products. They are available in a double-lumen configuration, one portal being used for nutrition and the other for blood drawing and other purposes. A special version of the catheter, consisting of a short wide-bore tube with a single cuff, has been used to maintain patients on hemodialysis for over one year (5) . It is placed into the internal jugular vein by direct cutdown and tunneled to emerge some distance from it. This method is useful where there is difficulty maintaining patency of an AVF or graft because of arterial disease or low blood pressure. A commercial version of this tube (HemoCath®) has now also become available in a double-lumen configuration, so that special dialysis equipment is not required. Although follow-up with this double-lumen version has been brief, the longevity of such silicone tubes is already established, and it may become an attractive alternative for selected patients. Another approach (6) is an indwelling central venous silicone catheter connected to a totally implanted reservoir. Access to the reservoir is by percutaneous puncture with a very fine bore needle of a special silicone rubber diaphragm. So for this device has been confined mostly to chemotherapy.
Another innovation, available as the DiaTap® button or Hernaslte" Device, consists of a rigid T Tube coated internally with material of low thrombogenicity and surrounded on the outside by a dacron cuff which encourages tissue invasion and fixation. For dialysis a special cannula is inserted through a self-sealing skin portal, thus eliminating needle punctures. Special training and equipment are required in the dialysis centre. In one version the device is inserted directly into a vein arterialized by an AVF, in another it is fused onto a PTFE graft attached to an artery and vein. Out of some 800 Hemosite devices implanted to date, the 24-month survival rate is 29% (8) , but most of these devices have been fol- lowed-up less than six months. The graftless version, prone to serious complications such as extrusion and hemorrhage, is steadily losing favor. The grafted device has all the problems of tube grafts, such as outflow occlusion and infection. Though it may fulfill a role in selected patients, its high cost may not be justified by any increased longevity over other existing methods. Selecting the optimum method, then, should be appropriate to the particular patient's needs. For dialysis the emphasis must be on preserving blood vessels, and the AVF remains the method of choice. In all hospitalized patients with renal failure, one upper extremity should be preserved from arterial and venous puncture. An AVF can often be created weeks before dialysis is needed, thus allowing the veins to dilate and making dialysis a simple ambulatory outpatient procedure. If the patient presents with severe renal failure, emphasis must still be on vessel preservation and external shunts should be avoided. Such patients may be managed by intermittent femoral venous cannulation, indwelling subclavian or jugular venous cannulas, or by peritoneal dialysis, and permanent access should be created as soon as possible.
Whenever possible, a distal AVF is constructed in a nondominant arm. This permits a more proximal fistula to be created later, should a problem develop. If the radial artery is unsuitable distally, it may be usable more proximally in the forearm. The brachial artery should be used only if both radial arteries are unsuitable throughout their entire course. Limiting the use of the brachial artery drastically reduces the possibility of causing ischemia of the extremity. A similar philosophy applies to grafts. Whenever possible, the arterial end of the graft should be attached distally. The venous end of the graft should be designed so as to allow later revision or extension of the graft to a more proximal site (Figures 3, 4) . The graft should be neither so superficial as to erode through the skin, nor so deep as to make punctures difficult. Curves or bends, if necessary, should be gentle and sharp kinks and twists should be avoided. To obviate loss of the graft from repeated needle punctures, short loops in the upper arm extending from the brachial artery to the axillary vein should be avoided. If the brachial artery must be used, the graft should be directed down towards the wrist and then back upwards in the forearm so as to provide a long loop ( Figure 5) . A further objection to the premature use of brachial artery and axillary vein is that should infection or venous outflow problems occur in such grafts, their correction may require major life-or limb-threatening operations. Likewise, the use of axillo-axillary grafts places the roots of both upper extremities at risk and may preclude future use of either upper limb. There may be difficulty in establishing access in patients with arterial disease, venous sclerosis, obesity, or poor blood pressure, but there is no justification for poor planning and bad judgment.
With regard to prosthetic devices, PTFE is preferred because of long-term patency and the ease and safety of reoperation. BCH were initially attractive, but their longterm hazards do not justify their use. So far graftless external devices have not fulfilled their promise, while the grafted devices have not demonstrated any superiority over PTFE grafts. Their exit portal adds to the risk of hemorrhage and infection, and the need to use the brachial artery is an additionlal disadvantage.
If both arms are unsuitable for access the lower extremity can be used. We create a loop graft between the superficial femoral artery and the saphenous vein, obtaining as much length as the anatomy of the patient allows. The risk of infection is higher in such grafts and the need to place needles in the high makes dialysis awkward. In lower extremity grafts, the arterial origin should be from the superficial femoral artery, because using the common femoral or the popliteal artery increases the risk of limb loss. Recently, modified PTFE grafts have become available, in which rigid polystyrene rings are incorporated around the outside of a 5-cm segment in the middle of 78 the graft. If the ringed segment is positioned where the graft is looped or crosses a joint, the possibility of narrowing of the lumen at these sites is reduced.
Finally, there remains the patient in whom none of these alternatives is suitable, because of arterial disease, hemodynamic instability or coagulation disorders. Two alternatives must then be considered. One is the insertion of a central venous catheter.
The single lumen version of this device has been successfully used for over a year, but lacks long-term follow-up. The second alternative is placing the patient on peritoneal dialysis, which may be the treatment of choice in some cases. 
